Salmonella Vaccine

  • Published: Nov 12, 2008
  • Earliest Priority: Nov 16 2000
  • Family: 14
  • Cited Works: 3
  • Cited by: 0
  • Cites: 2
  • Additional Info: Cited Works Full text
Abstract

The present invention relates to live attenuated Salmonella strains comprising a first attenuating mutation, that are not capable of making functional RecA. The invention also relates to these bacteria for use in vaccines. Furthermore, the invention relates to vaccines based upon these bacteria, to the use of such bacteria in the manufacture of vaccines and to methods for the preparation of such vaccines.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 12, 2008
  • Application: Nov 15, 2001
    EP EP 01996389 A
  • Priority: Nov 15, 2001
    EP EP 01996389 A
  • Priority: Nov 15, 2001
    EP EP 0113396 W
  • Priority: Dec 8, 2000
    EP EP 00204387 A
  • Priority: Nov 16, 2000
    EP EP 00204022 A

Download Citation


Sign in to the Lens

Feedback